Dah Sing MedTech (02543) public offering received 7558.40 times oversubscriptions, netting around HK$342 million in global offering.
Daheng Science and Technology (02543) announced the results of the distribution. The company globally issued 7.92 million H shares, with 10% of shares being publicly issued in Hong Kong...
Da Hing Group (02543) announced the distribution results, with the company issuing 7.92 million H shares globally. The public offering in Hong Kong accounted for 10%, while the international offering accounted for 90%. The offering price per share was HK$49.5, resulting in a net fundraising of approximately HK$342 million. The shares are expected to begin trading on the Hong Kong Stock Exchange on Tuesday, September 9, 2025 at 9:00 am Hong Kong time.
The public offering in Hong Kong was oversubscribed by 7,558.40 times, while the international offering was oversubscribed by 21.65 times.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
